C. Gleissner

C. Gleissner, P. Schnabel, H. Katus, 2005, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Determinants of B‐type natriuretic peptide plasma levels in the chronic phase after heart transplantation *

C. Gleissner, P. Schnabel, A. Remppis, 2005, Transplant international : official journal of the European Society for Organ Transplantation.

15-Deoxy-Δ12,14-Prostaglandin J2 Reinforces the Anti-Inflammatory Capacity of Endothelial Cells with a Genetically Determined Nitric Oxide Deficit.

C. Gleissner, M. Hecker, F. Leuschner, 2019, Circulation research.

Reduced hemoglobin after heart transplantation is no independent risk factor for survival but is associated closely with impaired renal function1

C. Gleissner, A. Remppis, H. Katus, 2004, Transplantation.

Histopathological assessment of calcification and inflammation of calcific aortic valves from patients with and without diabetes mellitus.

C. Gleissner, S. Body, E. Aikawa, 2017, Histology and histopathology.

Usefulness of Combining Clinical and Radiological Dental Findings for a More Accurate Noninvasive Age Estimation

C. Gleissner, A. Pistorius, B. Willershausen, 2007, Journal of forensic sciences.

High‐sensitive Troponin T measurements early after heart transplantation predict short‐ and long‐term survival

C. Gleissner, H. Katus, E. Giannitsis, 2013, Transplant international : official journal of the European Society for Organ Transplantation.

Polymerase chain reaction-based simultaneous detection of selected bacterial species associated with closed periapical lesions.

C. Gleissner, B. Willershausen, M. Geibel, 2005, European journal of medical research.

Myocardial Perfusion Reserve and Strain-Encoded CMR for Evaluation of Cardiac Allograft Microvasculopathy.

C. Gleissner, N. Osman, P. Schnabel, 2016, JACC. Cardiovascular imaging.

A human ex vivo atherosclerotic plaque model to study lesion biology.

C. Gleissner, H. Katus, T. Dengler, 2014, Journal of visualized experiments : JoVE.

Role of erythropoietin in anemia after heart transplantation.

C. Gleissner, R. Klingenberg, T. Dengler, 2006, International journal of cardiology.

Mechanisms by which diabetes increases cardiovascular disease.

C. Gleissner, K. Ley, J. Nadler, 2007, Drug discovery today. Disease mechanisms.

Induction of ILT expression on nonprofessional antigen presenting cells: Clinical applications.

C. Gleissner, T. Dengler, 2009, Human immunology.

Endothelial inducible costimulator ligand expression is increased during human cardiac allograft rejection and regulates endothelial cell‐dependent allo‐activation of CD8+ T cells in vitro

C. Gleissner, T. Giese, F. Autschbach, 2005, European journal of immunology.

Risk for periodontal disease in patients with longstanding rheumatoid arthritis.

C. Gleissner, A. Michel, W. Bolten, 1997, Arthritis and rheumatism.

Fermat's Cubic, Klein's Quartic and Rigid Complex Manifolds of Kodaira Dimension One

C. Gleissner, I. Bauer, 2019, Documenta Mathematica.

The impact of continuous erythropoietin receptor activators in patients after heart transplantation with multifactorial anemia with chronic kidney disease

C. Gleissner, H. Katus, L. Frankenstein, 2014 .

Optimisation of individual cardiovascular risk assessment in a German coronary artery disease cohort using a commercial test for genetic polymorphisms – a pilot study

C. Gleissner, H. Katus, C. Oberkanins, 2022, Acta cardiologica.

IL-17A Influences Essential Functions of the Monocyte/Macrophage Lineage and Is Involved in Advanced Murine and Human Atherosclerosis

Kristina M. Little, C. Gleissner, T. Giese, 2014, The Journal of Immunology.

Atherosclerosis Involved in Advanced Murine and Human Monocyte / Macrophage Lineage and Is IL-17 A Influences Essential Functions of the

Kristina M. Little, C. Gleissner, T. Giese, 2014 .

This information is current as Macrophages Transcriptome in Monocyte-Derived CXC Chemokine Ligand 4 Induces a Unique

Kristina M. Little, C. Gleissner, K. Ley, 2010 .

Adventitial tertiary lymphoid organ classification in human atherosclerosis.

C. Gleissner, F. Lasitschka, H. Katus, 2018, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.

Analysis of malignancies in patients after heart transplantation with subsequent immunosuppressive therapy

C. Gleissner, H. Katus, L. Frankenstein, 2014, Drug design, development and therapy.

Impact of the reduction of calcineurin inhibitors on renal function in heart transplant patients: a systematic review and meta‐analysis

C. Gleissner, L. Potena, F. Gueyffier, 2014, British journal of clinical pharmacology.

The Pluricanonical Systems of a Product-Quotient Variety

F. F. Favale, C. Gleissner, R. Pignatelli, 2018, Galois Covers, Grothendieck-Teichmüller Theory and Dessins d'Enfants.

The influence of surgical technique on early posttransplant atrial fibrillation – comparison of biatrial, bicaval, and total orthotopic heart transplantation

C. Gleissner, H. Katus, Dierk Thomas, 2017, Therapeutics and clinical risk management.

Comparison of a new chairside test for caries risk assessment with established methods in children.

C. Gleissner, B. Willershausen, A. Callaway, 2008, Schweizer Monatsschrift fur Zahnmedizin = Revue mensuelle suisse d'odonto-stomatologie = Rivista mensile svizzera di odontologia e stomatologia.

In vitro evaluation of enamel remineralisation by a casein phosphopeptide-amorphous calcium phosphate paste.

C. Gleissner, B. Willershausen, B. Schulz-Dobrick, 2009, Oral health & preventive dentistry.

Dystrophic epidermolysis bullosa: oral findings and problems.

C. Gleissner, B. Willershausen, B. Azrak, 2006, Special care in dentistry : official publication of the American Association of Hospital Dentists, the Academy of Dentistry for the Handicapped, and the American Society for Geriatric Dentistry.

Glycosylation in immune cell trafficking

C. Gleissner, K. Ley, M. Sperandio, 2009, Immunological reviews.

Accuracy of a chair-side test for predicting caries risk compared with established methods. A pilot study.

C. Gleissner, B. Willershausen, A. Callaway, 2010, Schweizer Monatsschrift fur Zahnmedizin = Revue mensuelle suisse d'odonto-stomatologie = Rivista mensile svizzera di odontologia e stomatologia.

Adventitial inflammation and its interaction with intimal atherosclerotic lesions

C. Gleissner, H. Katus, G. Korosoglou, 2014, Front. Physiol..

Platelet Chemokines in Vascular Disease

C. Gleissner, K. Ley, P. von Hundelshausen, 2008, Arteriosclerosis, thrombosis, and vascular biology.

CXCL4 Downregulates the Atheroprotective Hemoglobin Receptor CD163 in Human Macrophages

C. Gleissner, K. Ley, D. Böckler, 2010, Circulation Research.

Cxc Chemokine Ligand 4 Induces a Unique Transcriptome in Monocyte-derived Macrophages Address Correspondence and Reprint Requests To

Kristina M. Little, C. Gleissner, K. Ley, 2022 .

To change or not to change – That is the question: A qualitative study of lifestyle changes following acute myocardial infarction

C. Gleissner, Jennifer Nicolai, W. Eich, 2018, Chronic illness.

inhibition of B 7-1 ( cD 80 ) by rhuDex ® reduces lipopolysaccharide-mediated inflammation in human atherosclerotic lesions

C. Gleissner, H. Katus, T. Dengler, 2014 .

Effects of oral valganciclovir prophylaxis for cytomegalovirus infection in heart transplant patients

C. Gleissner, H. Katus, P. Schnitzler, 2012, Drug design, development and therapy.

Conversion to generic cyclosporine A in stable chronic patients after heart transplantation

C. Gleissner, H. Katus, L. Frankenstein, 2013, Drug design, development and therapy.

Constrictive Pericarditis in the Presence of Remaining Remnants of a Left Ventricular Assist Device in a Heart Transplanted Patient

C. Gleissner, M. Karck, F. Sedaghat-Hamedani, 2015, Case reports in transplantation.

Systematic RNA-interference in primary human monocyte-derived macrophages: A high-throughput platform to study foam cell formation

H. Erfle, C. Gleissner, C. Weber, 2018, Scientific Reports.

The Two Faces of Interleukin-17A in Atherosclerosis.

C. Gleissner, H. Katus, A. Doesch, 2016, Current drug targets.

An in vitro model to study heterogeneity of human macrophage differentiation and polarization.

C. Gleissner, H. Katus, A. Doesch, 2013, Journal of visualized experiments : JoVE.

CCL19 and CCL21 modulate the inflammatory milieu in atherosclerotic lesions

C. Gleissner, F. Lasitschka, H. Katus, 2014, Drug design, development and therapy.

Effects of Native and Modified Low-Density Lipoproteins on Monocyte Recruitment in Atherosclerosis

C. Gleissner, K. Ley, N. Leitinger, 2007, Hypertension.

Translational atherosclerosis research: From experimental models to coronary artery disease in humans.

C. Gleissner, 2016, Atherosclerosis.

Identification of novel downstream targets of platelet glycoprotein VI activation by differential proteome analysis: implications for thrombus formation.

C. Gleissner, E. Kremmer, K. Ley, 2010, Blood.

Identification of Specific Coronary Artery Disease Phenotypes Implicating Differential Pathophysiologies

C. Gleissner, W. März, M. Kleber, 2022, Frontiers in Cardiovascular Medicine.

Inflammatory therapeutic targets in coronary atherosclerosis—from molecular biology to clinical application

C. Gleissner, H. Katus, C. Erbel, 2014, Front. Physiol..

CXCL4-induced macrophages in human atherosclerosis.

C. Gleissner, G. Domschke, 2017, Cytokine.

The vulnerable vessel

C. Gleissner, 2015, Hämostaseologie.

Atherosclerosis Effects of Native and Modified Low-Density Lipoproteins on Monocyte Recruitment in

C. Gleissner, K. Ley, N. Leitinger, 2013 .

Differential regulation of aldose reductase expression during macrophage polarization depends on hyperglycemia

C. Gleissner, H. Katus, A. Doesch, 2016, Innate immunity.

Superior rejection profile during the first 24 months after heart transplantation under tacrolimus as baseline immunosuppressive regimen

C. Gleissner, H. Katus, P. Ehlermann, 2014, Drug design, development and therapy.

CXCL4-induced plaque macrophages can be specifically identified by co-expression of MMP7+S100A8+ in vitro and in vivo

C. Gleissner, F. Lasitschka, H. Katus, 2015, Innate immunity.

CXCL4-Induced Macrophages: A Novel Therapeutic Target in Human Atherosclerosis?

C. Gleissner, C. Erbel, 2012 .

CXCL4 Plasma Levels Are Not Associated with the Extent of Coronary Artery Disease or with Coronary Plaque Morphology

C. Gleissner, H. Katus, E. Giannitsis, 2015, PloS one.

Prevalence of M4 macrophages within human coronary atherosclerotic plaques is associated with features of plaque instability.

C. Gleissner, F. Lasitschka, H. Katus, 2015, International journal of cardiology.

CXCL4 in atherosclerosis: Possible roles in monocyte arrest and macrophage foam cell formation

C. Gleissner, K. Ley, 2007, Thrombosis and Haemostasis.

Threefolds Isogenous to a Product and Product quotient Threefolds with Canonical Singularities

C. Gleissner, 2016 .

Crystallographic Groups and Calabi-Yau 3-folds of Type $\mathrm{III}_0$

C. Gleissner, J. Kotonski, 2022, 2204.01414.

Rigid manifolds of general type with non-contractible universal cover

C. Gleissner, Davide Frapporti, 2021, Geometriae Dedicata.

The Classification of Regular Surfaces Isogenous to a Product of Curves with $\chi ({\mathcal {O}}_S)= 2$

C. Gleissner, 2013, 1310.3110.

Galectin-3 binding protein, coronary artery disease and cardiovascular mortality: Insights from the LURIC study.

C. Gleissner, M. Kleber, H. Katus, 2017, Atherosclerosis.

Functional association of a CD40 gene single nucleotide polymorphism with the pathogenesis of coronary heart disease.

C. Gleissner, M. Hecker, F. Leuschner, 2020, Cardiovascular research.

Periodontal disease in elderly patients.

C. Gleissner, B. Willershausen-Zönnchen, 1998, European Journal of Medical Research.

Macrophage Inflammatory Markers Are Associated With Subclinical Carotid Artery Disease in Women With Human Immunodeficiency Virus or Hepatitis C Virus Infection

C. Gleissner, Mardge H. Cohen, K. Anastos, 2014, Arteriosclerosis, thrombosis, and vascular biology.

Ezetimibe effectively lowers LDL‐cholesterol in cardiac allograft recipients on stable statin therapy

C. Gleissner, A. Remppis, H. Katus, 2008, Clinical transplantation.

Temporomandibular joint function in patients with longstanding rheumatoid arthritis - I. Role of periodontal status and prosthetic care - a clinical study.

C. Gleissner, B. Willershausen, W. Bolten, 2003, European journal of medical research.

The role of risk factors for periodontal disease in patients with rheumatoid arthritis.

C. Gleissner, B. Willershausen, W. Bolten, 1998, European journal of medical research.

Procedural advantages of a novel coronary stent design with ultra-thin struts and bioabsorbable abluminal polymer coating in an all-comers registry

C. Gleissner, H. Katus, R. Bekeredjian, 2018, Postepy w kardiologii interwencyjnej = Advances in interventional cardiology.

Advantageous effects of immunosuppression with tacrolimus in comparison with cyclosporine A regarding renal function in patients after heart transplantation

C. Gleissner, H. Katus, L. Frankenstein, 2015, Drug design, development and therapy.

Galectin-3 binding protein plasma levels are associated with long-term mortality in coronary artery disease independent of plaque morphology.

C. Gleissner, H. Katus, E. Giannitsis, 2016, Atherosclerosis.

A Family of Threefolds of General Type with Canonical Map of High Degree

C. Gleissner, Davide Frapporti, 2019, Taiwanese Journal of Mathematics.

On Threefolds Isogenous to a Product of Curves

C. Gleissner, Davide Frapporti, 2014, 1412.6365.

Mixed threefolds isogenous to a product

C. Gleissner, 2017, Journal of Algebra and Its Applications.

The classification of rigid hyperelliptic fourfolds

C. Gleissner, Andreas Demleitner, 2022, Annali di Matematica Pura ed Applicata.

Semi-projective representations and twisted representation groups

C. Gleissner, J. Kotonski, Massimiliano Alessandro, 2022, Communications in Algebra.

Towards a classification of rigid product quotient varieties of Kodaira dimension 0

Ingrid Bauer, Christian Gleissner, C. Gleissner, 2021, Bollettino dell'Unione Matematica Italiana.

CXCL4-induced PBMCs Modulate Vascular Extracellular Matrix through Wnt5a-CaMKII-dependent Release of Calcific Extracellular Vesicles and Matrix Metalloproteinase-7

C. Gleissner, H. Katus, N. Frey, 2023, bioRxiv.

CXC Chemokine Ligand 4 Induces a Unique Transcriptome in Monocyte-Derived Macrophages

Kristina M. Little, C. Gleissner, K. Ley, 2010, The Journal of Immunology.

CXCL4 Downregulates the Atheroprotective Hemoglobin Receptor CD163 in Human Macrophages

C. Gleissner, K. Ley, D. Böckler, 2010, Circulation research.

Platelet Chemokines in Vascular Disease

C. Gleissner, K. Ley, P. von Hundelshausen, 2008, Arteriosclerosis, thrombosis, and vascular biology.

On Rigid Manifolds of Kodaira Dimension 1

C. Gleissner, I. Bauer, J. Kotonski, 2022, 2212.05859.

Effects of vildagliptin (Galvus®) therapy in patients with type 2 diabetes mellitus after heart transplantation

C. Gleissner, H. Katus, T. Dengler, 2013, Drug design, development and therapy.

Subclinical atherosclerosis and chronic troponin elevation: the voice of silence in diabetics.

C. Gleissner, H. Katus, E. Giannitsis, 2012, Journal of the American College of Cardiology.

PARP inhibition in atherosclerosis and its effects on dendritic cells, T cells and auto-antibody levels

C. Gleissner, F. Lasitschka, C. Erbel, 2011, European Journal of Medical Research.

Effects of Native and Modified Low-density Lipoproteins on Monocyte Recruitment In

C. Gleissner, N. Leitinger, Klaus Ley Atherosclerosis, 2007 .

Platelet-derived chemokines in atherogenesis: what's new?

C. Gleissner, 2012, Current vascular pharmacology.